Self-Regulated Release of Active Pharmaceutical Ingredient for Niche Applications

Publication ID: 24-11857629_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Self-Regulated Release of Active Pharmaceutical Ingredient for Niche Applications,” Published Technical Disclosure No. 24-11857629_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857629_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,629.

Summary of the Inventive Concept

This inventive concept adapts the original self-regulated release technology for specialized markets, such as disaster relief, high-security environments, extreme weather conditions, remote medical assistance, and areas with limited medical resources.

Background and Problem Solved

The original patent addressed the need for abuse deterrent pharmaceutical compositions. However, these compositions may not be suitable for specific, narrow markets or unique operational environments. This inventive concept solves the problem by adapting the self-regulated release technology to cater to these niche applications.

Detailed Description of the Inventive Concept

The inventive concept comprises specialized variations of the original pharmaceutical composition, including a portable container with a water purification system for disaster relief, a secure, tamper-evident monitoring system for high-security environments, a moisture-resistant coating with a desiccant for extreme weather conditions, a telemedicine platform for remote medical assistance, and educational materials for areas with limited medical resources. These variations ensure the safe and effective administration of the pharmaceutical composition in these unique environments.

Novelty and Inventive Step

The new claims introduce novel and non-obvious adaptations of the original self-regulated release technology, including the integration of water purification systems, secure monitoring systems, moisture-resistant coatings, telemedicine platforms, and educational materials. These adaptations provide a new level of safety and efficacy in niche applications, distinguishing the inventive concept from the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include using different types of containers, monitoring systems, or coatings, or integrating additional features such as GPS tracking or biometric authentication. Variations could also include adapting the pharmaceutical composition for different types of medications or diseases.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including disaster relief, healthcare, pharmaceuticals, and medical technology. The target markets include governments, NGOs, hospitals, clinics, and pharmaceutical companies operating in niche environments.

CPC Classifications

SectionClassGroup
A A61 A61K47/02
A A61 A61K9/2009
A A61 A61K9/2027
A A61 A61K9/2077
A A61 A61K31/5517
A A61 A61K47/32

Original Patent Information

Patent NumberUS 11,857,629
TitleMethods and compositions for self-regulated release of active pharmaceutical ingredient
Assignee(s)Acurx Pharmaceuticals, Inc.